✦ LIBER ✦

Long-term safety and efficacy of 13.3mg/24h rivastigmine patch in severe Alzheimer's disease: ACTivities of daily living and cognitION (ACTION) study

✍ Scribed by Farlow, M.; Grossberg, G.; Sadowsky, C.; Meng, X.; Somgyi, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 24-week, open-label extension to the A

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy, safety and tolerability of riv

✍ Farlow, Martin; Meng, Xiangyi; Rensch, Scott; Somogyi, Monique 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy, safety and tolerability of riv

✍ Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 61 KB

Efficacy and safety of high-dose 13.3mg/

✍ Grossberg, G.; Farlow, M.; Meng, X.; Somogyi, M. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Efficacy, safety and tolerability of a h

✍ Grossberg, George; Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

High-dose 13.3mg/24h rivastigmine patch

✍ Molinuevo, J.L.; Cummings, J.; Frölich, L.; Galvin, J.; Krahnke, T.; Strohmaier, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB